Daniel B. Soland, CHIEF OPERATING OFFICER at IDERA PHARMACEUTICALS, INC. (IDRA), bought 50,000 shares at $1.19 ($60K) on 2021-06-18, disclosed to the SEC on 2021-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| KALV | BUY | 2019-09-30 | $213K | — | Filing → |
| ACAD | BUY | 2018-03-02 | $235K | — | Filing → |
| VPHM | SELL | 2012-03-06 | $990K | — | Filing → |